Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to GANDHI, VARSHA V
Item TypeName
Concept Pyrazoles
Academic Article The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.
Academic Article Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia.
Academic Article Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia.
Academic Article The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
Academic Article Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia.
Academic Article Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells.
Academic Article Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy.
Academic Article Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'.
Academic Article A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.
Academic Article Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Academic Article Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply.
Academic Article Development and characterization of prototypes for in?vitro and in?vivo mouse models of ibrutinib-resistant CLL.
Search Criteria
  • Pyrazoles